3-Isoxazolecarboxamide,N-(2,6-dimethylphenyl)-5-(hydroxymethyl)-

D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy[1].

[1] F Lepage, et al. New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur JMed Chem (1992) 27,581-593.